Revisiting an Expression Dataset of Discordant Inflammatory Bowel Disease Twin Pairs Using a Mutation Burden Test Reveals CYP2C18 as a Novel Marker. This evidence concerns the gene CYP2C18 and inflammatory bowel disease.